Saturday, 27 April 2024
Proteostasis Therapeutics Inc.
05:18 | 16/3/18
Post Analyst
Atomera Incorporated (NASDAQ:ATOM) recorded a trading volume of 1.07 million shares, above its 90-day volume average of 0.09 million shares.
more»
23:30 | 15/3/18
Wall Street Morning
On Wednesday, Proteostasis Therapeutics, Inc. (PTI) made the way into the market positive movers list with rising 2.74%.
more»
09:26 | 15/3/18
GlobeNewswire
CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other ...
more»
00:15 | 15/3/18
Market Exclusive
On March14, 2018, Proteostasis Therapeutics, Inc. (the “Company”) expects to disclose the following information in discussions to be held in connection with the Cowen& Co.
more»
11:07 | 14/3/18
Danvers Record
The Price to Book ratio for Proteostasis Therapeutics, Inc. NasdaqGM:PTI is 3.560229. The Price to book ratio is the current share price of a company divided by the book value per share.
more»
06:15 | 14/3/18
Investorplace.com
The company says that it believes the Breakthrough Therapy Designation for PTI-428 is a strong marker of how much its recent Phase 2 study results for its amplifier has succeeded.
more»
Commercial Vehicle Group, Inc. (NASDAQ: CVGI ) shares dropped 22 percent to $8.64 after the company posted downbeat results for its fourth quarter.
more»
05:30 | 14/3/18
Street Observer
Proteostasis Therapeutics, Inc. (PTI) stock price traded with surging change along with the volume 1.91 million shares on Monday trading session.
more»
02:07 | 14/3/18
CNA Finance
Proteostasis Therapeutics Inc PTI Stock News Proteostasis Therapeutics Inc (NASDAQ: PTI) is having an incredibly strong start to the trading session in the pre-market hours this morning, and for good reason.
more»
09:03 | 13/3/18
StreetInsider.com
Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing ...
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |